March 2012

Dear Colleagues: 

We are proud to announce in this Newsletter the new IASLC Fellowship/Young Investigator Award winners. IASLC’s Fellowship/Young Investigators awards are important activities for our organization and many investigators have over the years been able to start very successful careers in lung cancer translational/clinical science through our awards. 

In this Newsletter you will also find the announcement for the next Editor-in-Chief for our journal. The Journal of Thoracic Oncology (JTO) has seen a tremendous success since inception in 2005 under the leadership of Dr. Jett who has decided to “retire” from the position by the end of this year. 

Many international IASLC conferences are coming up. We would like to encourage IASLC members and colleagues to submit abstracts to the various I conferences as described below. 

The IASLC educational webinar series has been a great success and several new webinars are planned (see below). It is our hope that the IASLC members will take advantage of these excellent learning opportunities and promote the programs to other colleagues. 

Fred R. Hirsch, MD, PhD 

Editor, IASLC Newsletter 

Editor Search: Journal of Thoracic Oncology (JTO) 

The International Association for the Study of Lung Cancer (IASLC) has opened its search for candidates for a five-year term as Editor-in-Chief of the Journal of Thoracic Oncology. The Editor is responsible for oversight of each monthly issue and all supplements. The Editor works remotely from IALSC offices and with the publisher. The transition will begin Oct. 2012 with full responsibility on Jan. 1, 2013. 

In addition to being an IASLC member, the successful candidate will: 

• Be a recognized thoracic oncology thought leader 

• Be a proven scientific investigator in thoracic oncology 

• Have editorial experience or large-team leadership experience 

• Be able to meet the time demands of the Editor-in-Chief position 

• Have broad scientific and thoracic oncology interests and the ability to recognize scientific quality and innovation 

• Possess a high degree of integrity 

Inquiries and submissions should be sent to: 

Chair of the Editor Search Committee 

c/o IASLC Executive Office 

13100 E Colfax Ave Unit 10 

Aurora, CO 80011 

Or send documents electronically to: 

More information can be found on the IASLC website, 

Submissions should be delivered by July 1, 2012 and include a letter of interest, a one-to two-page vision statement for the Journal of Thoracic Oncology and curriculum vitae. 

Final interviews are scheduled for Saturday, Sept. 8 in Chicago, Illinois with the Search Committee and Board of Directors. 

IASLC Fellowship/Young Investigator Award winners: 

The IASLC BOD is proud to announce the following UASLC Fellowship/Young Investigator Awardees: 

Don X. Nguyen, Yale University School of Medicine: Young Investigator Award. 

Project title: Targeting lipid metabolic pathways in metastatic lung adenocarcinoma. 

Jih-Hsiang Lee, National Taiwan University Hospital: Young Investigator Award. 

Project title: Quantitative measurement of activating mutation from circulation of lung adenocarcinoma patients by deep sequencing. 

Alexander Drilon, Memorial Sloan Kettering Cancer Center: Fellowship Award. Mentor: Mark Kris, MD. 

Project title: KIF5B/RET: A potential therapeutic target in lung cancer. 

Anne-Marie Baird, St. James Hospital, Dublin, Ireland: Fellowship Award. 

Mentor: Kenneth O’Byrne. 

Project title: Targeting NFκB to re-sensitize cisplatin resistant NSCLC cells. 

Please remember to pay the IASLC membership fee 2012 - $200 

Registering online is fast and easy! Visit for more information. 

IASLC members will be sent renewal reminders and invoices. Register now so there will no interruption to your JTO subscription, and to receive discounts on 2012 meeting fees. Please contact the Membership Department if you need any assistance paying your dues: 

FREE IASLC Membership for Fellows: 

Did you know that IASLC offers a FREE membership for fellows? This complimentary membership includes online access to the JTO, as well as additional discounts and educational programs. It is a great way to expose clinical fellows to the benefits of IASLC membership and introduce them to IASLC activities. The complimentary Fellow membership is available for a maximum of two years, and requires a verification letter from the program director stating the term dates of the fellowship. Please forward this link to any fellows you know and encourage them to join immediately:

3rd ELCC (ESMO/IASLC) Lung Cancer Conference, 
April 18 – 21, 2012, Geneva, Switzerland 

For more information

If you already planning on attending ELCC 2012 then we have a great round-up of event content here for you. If you are still unsure about attending, then we have plenty here to help convince you! Remember, ESMO and IASLC members receive a savings of € 150!! 

5th Latin American Conference on Lung Cancer 

The 5th Latin American Conference is now under planning and both an exciting educational – and scientific program have been developed, including sessions on the new staging, lung cancer screening and molecular testing for personalized medicine. Abstract deadline is March 30, 2012. For more information or

Submit an abstract for the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology 

Now through April 5, 2012, abstracts are being accepted for the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology. The symposium will offer valuable information on the multidisciplinary treatment approach for thoracic malignancies. Speakers will address a variety of strategies to treat lung and esophageal cancer, malignant mesothelioma and metastatic cancers of the chest. In addition, the symposium will highlight the translation of novel clinically significant discoveries into clinical practice. Submit today. The meeting will be held September 6-8, 2012, at the Chicago Marriott Downtown Magnificent Mile. 

IASLC Career Development Committee: 

IASLC has formed a new Career Development Committee, as part of the Strategic Plan adopted by the IASLC Board of Directors in 2011. The IASLC Career Development Committee will focus on mentoring, career development, networking, and assessing IASLC educational programs for their ability to meet young members’ professional needs. Self-nominations to this new Committee are sought from IASLC members from all specialties and regions of the World. Senior IASLC members will also participate in this committee and give special attention to the young members’ educational and career advancement needs and will introduce committee members to IASLC programs and organizational structure. To find out more information and to self-nominate, please visit:

IASLC Web-based Education Programs 

IASLC has introduced new educational programs on its Web site ( for its members and for healthcare professionals who are managing patients with lung cancer. The first program titled, “New Developments in Non-Small Cell Lung Cancer” features Professor Peter Goldstraw, MD, in a two-part presentation, that reviews the fundamentals of the new lung cancer staging system and examines the role of the TNM staging system of patients with small-cell lung cancer. The new, updated IASLC nodal staging map is also reviewed. In another presentation, Paul Bunn, Jr, MD, addresses the incorporation of molecular testing into the standard diagnostic workup of patients with NSCLC, and the selection of appropriate treatment for patients. The program concludes with case-study presentations by Drs. Bunn and Harvey I. Pass, illustrating the use of the new staging system and molecular testing. 

Upcoming webinars include: “Clinical Implications of the New Adenocarcinoma Classification” 

Women and Lung Cancer - CME-certified Audio-guided Web course 

The International Association for the Study of Lung Cancer (IASLC) has partnered with joint sponsors Penn State College of Medicine and Rockpointe to bring a CME-certified webcourse to oncologists caring for patients with lung cancer. 

Joan H. Schiller, MD chairs the program with faculty Edward Garon, MD and Heather Wakelee, MD. Program Description: The treatment of NSCLC has been revolutionized in the past decade, with an increased understanding of the need for individualization of therapy. Histologic and molecular features of NSCLC predict response to targeted agents and certain chemotherapies. Gender should also play a role in treatment, as lung cancer biology, natural history, and treatment outcomes vary between men and women. 

This educational initiative was designed to help community oncologists integrate personalization of therapy into the treatment of NSCLC patients. The goal is to enhance knowledge, clinical competence, and performance of clinicians with respect to diagnosis, staging, and treatment options – thereby leading to improved patient outcomes. The activity is supported by an educational grant from Lilly, USA and Genentech BioOncology. 

Click here to view activity:

IASLC Staging Manual: 

The IASLC Staging Manual and Handbook in Thoracic Oncologic has now surpassed 35,000 copies sold worldwide. In addition, the Staging Posters and Reference Cards continue to be popular reference aids of the 7th edition staging system for practitioners and tumor boards. IASLC members can continue to order these publications and products at special member pricing (; contact for further information). 

In addition, translations of these publications have been completed or are in process in multiple languages: Chinese, Italian, Japanese, Polish, and Turkish. Discussions about future translations in Spanish, Arabic, and Russian are ongoing. 

The new IASLC Staging Manual has been published in different formats. Several years of work from the IASLC Staging Committee and particularly the chair Dr. Peter Goldstraw, has resulted in a formal staging manual. The book and the “pocket-cards” can be ordered at 



iPhone/iPad Staging Atlas

JTO Mobile options 

JTO is available for your iPhone, Blackberry, or Android phone, in a view designed for easy reading on a small screen. Type into your phone’s browser to access the site. You can view current issue table of contents, most viewed articles, most emailed articles, or search across issues. If you have created a user name and password on the desktop version of, you can use that same log in information to view full text articles, complete with illustrations. 

IASLC Textbook – Editor in Chief: Harvey I. Pass, MD 

Lung Cancer Book from Lippincott: The Fourth Edition of Principles and Practice of Lung Cancer, edited by Harvey I. Pass, MD et al is now available. For more information about the 1040 page book, with 330 illustrations (ISBN-10:0-7817-7365-2) or 




Upcoming IASLC Workshops/Meetings 2012- 2015 

Radiotherapy Workshop 

Geneva, Switzerland 

April 17-18, 2012 


3rd European Lung Cancer Conference 

April 18 - 21, 2012 

Location: Geneva, Switzerland 

More information: 

Houston Lung Symposium 

Houston, TX 

April 28 – 29, 2012 


Quantitative CT Imaging in Early Stage NSCLC 

Silver Spring, MD 

May 3-4, 2012 


13th Central European Lung Cancer Conference 

Prague, Czech Republic 

June 24 – 27, 2012 


3rd International Conference in Thoracic Oncology 

Naples, Italy 

June 28-30, 2012 


13th International Lung cancer Congress 

Huntington beach, CA 

July 19-22, 2012 


5th Latin American Lung Cancer Conference 

July 25-27, 2012 

Location: Rio de Janeiro, Brazil 

More information: 

Chicago Multidisciplinary Symposium in Thoracic Oncology 

September 6-8, 2012 

Location: Hotel Marriott, Chicago, Illinois, U.S.A. 

More information: 

3rd International thoracic Oncology Congress 

Dresden, Germany 

September 13-15, 2012 


5th Asia Pacific Lung Cancer Conference 

November 26-28, 2012 Location: Hilton Sea Hawk, Fukuoka, Japan 

More information: 


15th World Conference on Lung Cancer 

October 27-31, 2013 

Location: Sydney, Australia 

More information: 


16th World Conference on Lung Cancer 

September 4-8, 2015 

Location: Denver, Colorado, USA 

More information: